Not yet recruiting
Colitis ulcerative
Not yet recruitingStudy on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis
Registered drugNo placebo
Study on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis
Registered drugNo placebo
- Disease:Colitis ulcerative
- Substances:VedolizumabOD-07656 hydrochloride
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Vedolizumab
